Eptinezumab for chronic headache in intracranial hypertension
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether eptinezumab, a medication that reduces a brain chemical called CGRP (involved in migraines), can help reduce headaches in people with idiopathic intracranial hypertension (IIH)—a condition where pressure builds up around the brain. The study wants to see if this treatment safely reduces headache frequency and severity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 55 years old
- You have been diagnosed with idiopathic intracranial hypertension (IIH), with or without optic nerve swelling
- You have chronic headaches related to your IIH, with at least 15 headache days per month
- At least 8 of your monthly headaches feel like migraines (throbbing, often one-sided)
- You commit to keeping a detailed headache diary throughout screening and the trial
- You use effective birth control during the trial and for at least 5 months after your last study dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if tirzepatide can help lower the pressure inside your skull caused by a condition called Idiopathic Intracranial Hypertension. It's designed for people with a BMI of 30 or higher who have swelling of the optic nerve.
This trial tests whether placing a stent (a small tube) in a narrowed brain vein can help reduce pressure in the head in people with Intracranial Hypertension who have been on acetazolamide for over a year. It may be an option if you still have high pressure despite medication.
This trial tests whether placing a small tube (stent) in a narrowed brain vein can help people with newly diagnosed intracranial hypertension (high pressure in the head) that causes vision problems. It is for those who have not yet taken standard medication and have specific vein narrowing seen on MRI.
This study looks at how body weight (BMI) affects how well people with Idiopathic Intracranial Hypertension (IIH) respond to treatment. It may help doctors understand if weight influences symptom relief.
This trial tests if a small tube called a stent can be placed in a vein in your brain to relieve high pressure. It may help people with headaches, vision changes, or other symptoms from this condition.
This trial tests if a medication called eptinezumab can help stop headaches that start after a head injury. If you have new headaches since your injury and they happen within the first 8 weeks, this study may offer early treatment.
Hear when a new Idiopathic Intracranial Hypertension (IIH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.